Login to Your Account



Yisheng looking to Singapore for initial rabies vaccine launch

By Pearl Liu
Staff Writer

Tuesday, January 5, 2016

HONG KONG – Chinese vaccine developer Yisheng Biopharma Co. Ltd. is looking at Southeast Asian markets as the first big opportunity for the company's rabies vaccine, but any marketing will not happen for at least two years.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription